Empagliflozin 10 MG [Jardiance]

DRUG3 trials

Sponsors

Medical University of Vienna, Seoul National University Bundang Hospital, Ain Shams University

Conditions

Chronic Kidney Disease stage3Chronic Kidney Disease stage4Diabete MellitusDiabetes Mellitus, Type 2Diabetic Kidney DiseaseFatty LiverHeart FailureRemodeling, Left Ventricle

Phase 2

EMPRA (EMPagliflozin and RAs in Kidney Disease)

CompletedNCT03078101

Medical University of ViennaChronic Kidney Disease stage3, Chronic Kidney Disease stage4, Diabetes Mellitus, Type 2 +1

Start: 2017-04-15End: 2019-08-07Updated: 2019-08-08

Effect of Empagliflozin 10 vs 25 mg on LV Remodeling in Diabetic Patients With Anterior STEMI With Reduced LVEF

CompletedNCT07169981

Ain Shams UniversityDiabete Mellitus, Heart Failure, Remodeling, Left Ventricle

Start: 2023-07-12End: 2025-06-17Updated: 2025-09-12

Phase 4

Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes

RecruitingNCT06989723

Seoul National University Bundang HospitalFatty Liver, Type 2 Diabetes

Start: 2025-01-01End: 2027-06-30Target: 120Updated: 2025-05-25